Atossa Genetics Moves Phase 2 Fulvestrant Study

SHARE

Atossa Genetics will relocate its phase 2 study of fulvestrant from Columbia University Medical Center to Montefiore Medical Center to accommodate the appointment of Dr. Sheldon Feldman, the study’s principal investigator, to chief, division of Breast Surgery & Breast Surgical Oncology, director, Breast Cancer Services and professor, Department of Surgery at the Montefiore Medical Center.

“Although enrollment in the study has been slower than we expected, particularly as the study site is being moved, we expect that Montefiore’s large hospital system and leading breast cancer care center will facilitate faster enrollment, which we now anticipate completing by August 2017,” Steven Quay, CEO of Atossa stated.

SHARE

LEAVE A REPLY